Relebactam Anhydrous

CHEMBL3112741 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

348.4 g/mol

LogP

-3.6

Phase

4

Relebactam anhydrous is the anhydrous form of relebactam, a diazabicyclooctane beta-lactamase inhibitor combined with imipenem-cilastatin for treatment of resistant Gram-negative bacterial infections. See relebactam for complete pharmacological details.

Moleküler Ağırlık

348,3800 g/mol

LogP

-3,60

TPSA

137,00 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Infectious Disease Hematology Oncology Obesity

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O

InChI

InChI=1S/C12H20N4O6S/c17-11(14-8-3-5-13-6-4-8)10-2-1-9-7-15(10)12(18)16(9)22-23(19,20)21/h8-10,13H,1-7H2,(H,14,17)(H,19,20,21)/t9-,10+/m1/s1

Molecular Formula

C12H20N4O6S

HBD / HBA

3 / 7

Döndürülebilir Bağlar

4

Ağır Atomlar

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Relebactam anhydrous is the anhydrous form of relebactam, a diazabicyclooctane beta-lactamase inhibitor combined with imipenem-cilastatin for treatment of resistant Gram-negative bacterial infections. See relebactam for complete pharmacological details.

Yes, Relebactam Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3112741. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 44129647. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Relebactam Anhydrous PillFYI'da

Yapı

Hızlı Veriler

Formül: C12H20N4O6S
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.